About us

At Hexaphoenix, we provide the latest technological innovation with world class manufacturing and process excellence. Hexaphoenix is a young pharmaceutical company that provides wealth expertise to connect Companies, People and Knowledge. 

We are a preferred global partner to the pharmaceutical, biotech and specialty therapeutically markets. Our solutions improve life quality by preventing illness, enabling healthier lifestyles and supporting a safe environment. We offer Finished Pharmaceutical and Nutritional products at world class approved facilities from WHO GMP and EUGMP and also provide Contract Manufacturing Service with Customer Own brand.

Our Goal

With over 10 years’ experiences in pharmaceuticals and nutritional products to develop and marketing. we commit to provide world class quality products. We offer Contract Manufacturing Service from European approved products.

Vision

To be excellent

global pharma company by enriching our people with hail and hearty living.

Mission

The essence of

our mission is a commitment to customer service by meeting or exceeding clients’ expectation in terms of quality, cost and efficiency.

Strength: 100mg /200mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 75mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg /500mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/20mg/30mg/40mg/60mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30mg/60mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 40/160mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 500mg/750mg/1000mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: Prochlorperazine |  Tablet |  5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 10 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 7.5mg/5ml, 30mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5/10/20/25mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 375mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD / ACTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 250mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 800mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg / 7.5mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 5mg/5ml

Dosage: Syrup

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 30 mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 50/100mg

Dosage: Capsules

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 12.5/25/50/100mg

Dosage: Tablets

Approved Authority: UKMHRA Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: UK not available

Strength: 0.5mg / 0.75mg / 1.0mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg + 125mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 2mg

Dosage: ODT (Lingual) Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 8mg /16mg / 24mg /48mg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 0.5mg / ml

Dosage: Oral Solution

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 500 mg / 1000mg

Dosage: Granules in Sachet

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 1mg/5mg/10mg

Dosage: Film Coated Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 62.5 mcg

Dosage: Tablets

Approved Authority: EUGMP Approved

Dossiers Available: eCTD

Bioequivalence (BE/BA) study: Available

Market Availability: All market available, Ask More details for availability

Strength: 5 IU and 10 IU

Dosage: Injection

Approved Authority: WHO Prequalified and From EUGMP Approved Plant

Dossiers Available: Ready CTD

Bioequivalence (BE/BA) study: Not Required for Injection

Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.